Purple Biotech Q3 EPS $(0.23), Inline; $15.9M In Cash, Cash Equivalents And Short-term Deposits. In October 2023 The Company Raised An Additional Gross Amount Of $5M Extended The Cash Runway To The Second Half Of 2025
Author: Benzinga Newsdesk | November 21, 2023 07:56am
Purple Biotech (NASDAQ:
PPBT) reported quarterly losses of $(0.23) per share which met the analyst consensus estimate. This is a 14.81 percent increase over losses of $(0.27) per share from the same period last year.
Posted In: PPBT